Compounds > 2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione
Page last updated: 2024-08-26

2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione and Dyskinesia, Medication-Induced

2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione has been researched along with Dyskinesia, Medication-Induced in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casey, DE; Gerlach, J; Noring, U; Povlsen, UJ1

Trials

1 trial(s) available for 2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione and Dyskinesia, Medication-Induced

ArticleYear
Effect of a cholinomimetic drug (RS 86) in tardive dyskinesia and drug-related parkinsonism.
    Psychopharmacology, 1984, Volume: 84, Issue:4

    Topics: Adult; Aged; Antipsychotic Agents; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Parasympathomimetics; Parkinson Disease, Secondary; Random Allocation; Salivation; Succinimides

1984